Table 2.
Clinical-pathological characteristics of soft tissue sarcoma patient
| Overall population N (%) | PLR | NLR | |||||
|---|---|---|---|---|---|---|---|
| <133.915 | ≥133.915 | P | <2.5 | ≥2.5 | P | ||
| N = 146 | N = 76 | N = 160 | N = 62 | ||||
| Age at operation(years) | 0.091 | 0.067 | |||||
| <65 | 205(92.3) | 138(94.5) | 67(88.2) | 151(94.4) | 54(87.1) | ||
| ≥65 | 17(7.7) | 8(5.5) | 9(11.8) | 9(5.6) | 8(12.9) | ||
| Gender | 0.02 | 0.206 | |||||
| Female | 96(43.2) | 55(37.7) | 41(53.9) | 65(40.6) | 31(50.0) | ||
| Male | 126(56.8) | 91(62.3) | 35(46.1) | 95(59.4) | 31(50.0) | ||
| Performance status | 0.002 | <0.001 | |||||
| 0 ~ 1 | 173(77.9) | 123(84.2) | 50(65.8) | 137(85.6) | 35(58.1) | ||
| ≥2 | 49(22.1) | 23(15.8) | 26(34.2) | 23(14.4) | 26(41.9) | ||
| Diabetes mellitus | 0.013 | 0.067 | |||||
| Yes | 4(1.8) | 0(0) | 4(5.3) | 1(0.6) | 3(4.8) | ||
| No | 218(98.2) | 146(100.0) | 72(94.7) | 159(99.4) | 59(95.2) | ||
| Cardiopulmonary disease | 1.000 | 1.000 | |||||
| Yes | 12(5.4) | 8(5.5) | 4(5.3) | 9(5.6) | 3(4.8) | ||
| No | 210(94.6) | 138(94.5) | 72(94.7) | 151(94.4) | 59(95.2) | ||
| Ever smoked | 0.003 | 0.300 | |||||
| Yes | 34(15.3) | 30(20.5) | 4(5.3) | 27(16.9) | 7(11.3) | ||
| No | 188(84.7) | 116(79.5) | 72(94.7) | 133(83.1) | 55(88.7) | ||
| Tumor depth | 0.024 | 0.001 | |||||
| Superficial | 87(39.2) | 65(44.5) | 22(28.9) | 74(46.3) | 13(21.0) | ||
| Deep | 135(60.8) | 81(55.5) | 54(71.1) | 86(53.8) | 49(79.0) | ||
| Tumor grade | 0.028 | 0.047 | |||||
| G1 | 65(29.3) | 50(34.2) | 15(19.7) | 55(34.4) | 10(16.1) | ||
| G2 | 99(44.6) | 65(44.5) | 34(44.7) | 67(41.9) | 32(51.6) | ||
| G3 | 36(16.2) | 17(11.6) | 19(25.0) | 23(14.4) | 13(21.0) | ||
| Unknown | 22(9.9) | 14(9.6) | 8(10.5) | 15(9.4) | 7(11.3) | ||
| Tumor size | 0.005 | <0.001 | |||||
| <5 cm | 105(47.3) | 79(54.1) | 26(34.2) | 88(55.0) | 17(27.4) | ||
| ≥5 cm | 117(52.7) | 67(45.9) | 50(65.8) | 72(45.0) | 45(72.6) | ||
| Tumor site | 0.282 | 0.002 | |||||
| Upper extremity | 21(9.5) | 11(7.5) | 10(13.2) | 18(11.3) | 3(4.8) | ||
| Lower extremity | 60(27.0) | 41(28.1) | 19(25.0) | 46(28.8) | 14(22.6) | ||
| Thoracic/trunk | 77(34.7) | 54(37.0) | 23(30.3) | 62(38.8) | 15(24.2) | ||
| Intra-abdomina | 35(15.8) | 19(13.0) | 16(21.1) | 17(10.6) | 18(29.0) | ||
| Head-neck | 29(13.1) | 21(14.4) | 8(10.5) | 17(10.6) | 12(19.4) | ||
| AJCC stage | 0.056 | 0.002 | |||||
| IA + IB | 68(30.6) | 52(35.6) | 16(21.1) | 57(35.6) | 11(17.7) | ||
| IIA + IIB | 107(48.2) | 68(46.6) | 9(51.3) | 77(48.1) | 30(48.4) | ||
| III + IV | 34(15.3) | 17(11.6) | 17(22.4) | 16(10.0) | 18(29.0) | ||
| Unknown | 13(5.9) | 9(6.2) | 4(5.3) | 10(6.3) | 3(4.8) | ||
Bold print indicates statistical significance